Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 18 | 1,128 | 8,158 | 17,530 | 0 |
| Cost of Goods | N/A | 1,803 | 600 | 28 | N/A |
| Gross Profit | 18 | -675 | 7,558 | 17,502 | N/A |
| Operating Expenses | 109,496 | 77,308 | 28,108 | 16,732 | 12,410 |
| Operating Income | -109,478 | -77,180 | -19,950 | 798 | -12,410 |
| Interest Expense | 0 | 0 | 31 | 2,739 | 279 |
| Other Income | 4,332 | 1,648 | 0 | 0 | 0 |
| Pre-tax Income | -105,146 | -75,532 | -19,981 | -1,941 | -12,689 |
| Income Tax | N/A | 125 | 19 | N/A | N/A |
| Net Income Continuous | -105,146 | -75,657 | -20,000 | -1,941 | -12,689 |
| Net Income | $-105,146 | $-75,657 | $-20,000 | $-1,941 | $-12,689 |
| EPS Basic Total Ops | -5.12 | -4.80 | -2.14 | -1.91 | -18.83 |
| EPS Basic Continuous Ops | -5.12 | -4.80 | -2.06 | -0.84 | -17.65 |
| EPS Diluted Total Ops | -5.12 | -4.80 | -2.14 | -1.91 | -18.83 |
| EPS Diluted Continuous Ops | -5.12 | -4.80 | -2.06 | -0.84 | -17.65 |
| EPS Diluted Before Non-Recurring Items | -5.12 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-109,754 | $-76,763 | $-19,743 | $1,011 | $-12,297 |